KaloBios Pharmaceuticals, Inc. (KBIO)


Other OTC - Other OTC Delayed Price. Currency in USD
3.27-0.11 (-3.25%)
At close: 3:38 PM EDT
People also watch:
CANFPBMDMCURSPHSAEZS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.32
Prev Close3.38
Bid0.00 x
Ask0.00 x
Day's Range3.21 - 3.55
52wk Range3.18 - 5.21
1y Target EstN/A
Market Cap48.73M
P/E Ratio (ttm)-0.38
Beta3.26
Volume8,309
Avg Vol (3m)17,538
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    KaloBios CEO to Participate in Pharmaceutical Strategy Conference

    BRISBANE, Calif., Sept. 27, 2016-- KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant, ...

  • Associated Press7 days ago

    KaloBios reports 1Q loss

    The Brisbane, California-based company said it had a loss of $1.22 per share. Losses, adjusted for non-recurring costs, came to 65 cents per share. In the final minutes of trading on Friday, the company's ...

  • Associated Press7 days ago

    KaloBios reports 2Q loss

    On a per-share basis, the Brisbane, California-based company said it had a loss of $2.63. Losses, adjusted for non-recurring costs, were $1.51 per share. In the final minutes of trading on Friday, the ...